APRE's three largest insider shareholders as of August 04, 2026 are Oren Gilad (President/Ceo, 393.89K shares), Christian S Schade (Chairman Ceo, 259.25K shares), Marc Duey (Director, 256.15K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John B Iii Henneman | - | 10,229 | 0 | 09 Jun, 2025 |
| Christian S Schade | Chairman Ceo | 259,246 | 0 | 01 Aug, 2022 |
| Scott M Coiante | Svp, Chief Financial Officer | 145,065 | 0 | 01 Aug, 2022 |
| Jean-Pierre Bizzari | - | 1,045 | 0 | 09 Jun, 2025 |
| Richard Peters | - | 3,119 | 0 | 09 Jun, 2025 |
| John P. Hamill | Srvp/Cfo/Prin Fin Acct Ofcr | 43,528 | 0 | 16 Mar, 2026 |
| Michael Grissinger | - | 2,889 | 0 | 09 Jun, 2025 |
| Michael Aaron Kelly | - | 4,610 | 0 | 01 Jul, 2021 |
| Gregory Alan Korbel | Svp, Chief Operating Officer | 45,762 | 0 | 01 Aug, 2022 |
| Lars B. Abrahmsen | Svp, Chief Scientific Officer | 43,700 | 0 | 14 Mar, 2022 |
| Bernd R. Seizinger | - | 45,775 | 0 | 09 Jun, 2025 |
| Eyal C. Attar | Svp, Chief Medical Officer | 57,233 | 0 | 07 Jun, 2022 |
| Fouad Namouni | - | 4,610 | 0 | 01 Jul, 2021 |
| Gabriela Gruia | - | 1,045 | 0 | 09 Jun, 2025 |
| Marc Duey | - | 256,155 | 0 | 11 Dec, 2025 |
| Rifat Pamukcu | - | 5,446 | 0 | 09 Jun, 2025 |
| Oren Gilad | President/Ceo | 393,895 | 0 | 16 Mar, 2026 |
| Nadeem Q. Mirza | Chief Medical Officer | 6,730 | 0 | 02 May, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Mar, 2026 | John P. Hamill | Pre-Funded Warrant | A | 30,978 | $0.81 | 30,978 | D | P |
| 31 Mar, 2026 | Richard Peters | Pre-Funded Warrant | A | 123,915 | $0.81 | 123,915 | D | P |
| 31 Mar, 2026 | John P. Hamill | Common Warrant | A | 30,978 | - | 30,978 | D | P |
| 31 Mar, 2026 | Richard Peters | Common Warrant | A | 123,915 | - | 123,915 | D | P |
| 12 Mar, 2026 | Oren Gilad | Common Stock | A | 20,175 | $0.00 | 393,895 | D | A |
| 12 Mar, 2026 | Oren Gilad | Common Stock | A | 20,175 | $0.00 | 393,895 | D | A |
| 12 Mar, 2026 | Oren Gilad | Common Stock | A | 20,175 | $0.00 | 393,895 | D | A |
| 12 Mar, 2026 | John P. Hamill | Common Stock | A | 10,095 | $0.00 | 43,528 | D | A |
| 12 Mar, 2026 | John P. Hamill | Stock Options (Right to Buy) | A | 40,380 | $0.00 | 40,380 | D | A |
| 12 Mar, 2026 | Oren Gilad | Stock Options (Right to Buy) | A | 80,700 | $0.00 | 80,700 | D | A |
| 12 Mar, 2026 | Oren Gilad | Stock Options (Right to Buy) | A | 80,700 | $0.00 | 80,700 | D | A |
| 12 Mar, 2026 | Oren Gilad | Stock Options (Right to Buy) | A | 80,700 | $0.00 | 80,700 | D | A |
| 30 Jan, 2026 | Oren Gilad | Common Stock | A | 28,100 | $0.89 | 373,720 | D | P |
| 30 Jan, 2026 | Oren Gilad | Common Stock | A | 28,100 | $0.89 | 373,720 | D | P |
| 30 Jan, 2026 | Oren Gilad | Common Stock | A | 28,100 | $0.89 | 373,720 | D | P |
| 30 Jan, 2026 | John P. Hamill | Common Stock | A | 5,700 | $0.89 | 33,433 | D | P |
| 30 Jan, 2026 | John P. Hamill | Common Warrant | A | 5,700 | - | 5,700 | D | P |
| 30 Jan, 2026 | Oren Gilad | Common Warrant | A | 28,100 | - | 28,100 | D | P |
| 30 Jan, 2026 | Oren Gilad | Common Warrant | A | 28,100 | - | 28,100 | D | P |
| 30 Jan, 2026 | Oren Gilad | Common Warrant | A | 28,100 | - | 28,100 | D | P |